The first full week of April closed with two more clinical-stage biotech companies joining the Nasdaq, each developing a drug to address rare disorders. First up was VectivBio, which raised $127.5 million to complete pivotal tests of a drug
Dive Brief: Medical device companies spent more money in non-research payments to physicians between 2014 and 2017 than drug companies, an analysis published Monday in the journal Health Affairs found. The payments covered services like royalties, consulting and speaking fees,
BrightInsight’s co-founders, from left to right: Vice President of Engineering and Data Science Ben Lee, CTO Ferry Tamtoro, CEO Dr. Kal Patel. Photo credit: BrightInsight Developing a digital health platform can be a time consuming process. BrightInsight, a San Jose-based
After the rain, comes the rainbow; after the night there’s morning; and, after an ending there’s a new beginning – or so we hope. As the world resets from the aftermath of Covid-19, pharmaceutical industry leaders are taking stock in
Dive Brief: The U.S. Federal Trade Commission will join European, British and Canadian regulators, as well as with counterparts at the U.S. Justice Department and states attorneys general, to update their approach to reviewing pharmaceutical acquisitions, a move the commission’s
Some state attorneys general and opioid addiction activists pushed back Tuesday against a settlement offer from OxyContin maker Purdue Pharma, saying it didn’t include enough money and goes too far in protecting the company and family members who own it
Purdue Pharma filed a bankruptcy plan on Monday that would resolve thousands of opioid lawsuits by restructuring the OxyContin maker into an entity that would steer profits to plaintiffs and require the company’s Sackler family owners to contribute nearly
In a filing that signifies the beginning of the end of the country’s most notorious manufacturer of prescription opioids, Purdue Pharma submitted its bankruptcy restructuring plan just before midnight on Monday. The blueprint requires members of the billionaire Sackler family
Viewers who caught Oprah Winfrey’s interview of Meghan Markle and Prince Harry heard bombshell revelations about the strained relationship the couple has with the royal family and alleged racism among its members. But viewers in the U.K. and around
Blue Cross and Blue Shield of Minnesota has filed a class-action lawsuit against the infamous “pharma bro” Martin Shkreli and Vyera Pharmaceuticals, alleging they engaged in illegal drug pricing. The suit, filed March 4, claims that Vyera Pharmaceuticals intentionally monopolized